Orgenesis Inc.

ORGS · · SIC 2834: Pharmaceutical Preparations
278
SEC Filings

Business Summary

PART I (All monetary amounts are expressed in thousands of US dollars (unless stated otherwise), except for share and loss per share amounts.) On September 20, 2024, the Company implemented a 1-for-10 reverse stock split (the Reverse Split) of its authorized and outstanding shares of Common Stock. All share and per share amounts in these financial statements have been retroactively adjusted to reflect the Reverse Split as if it had been effected prior to the earliest financial statement period i...

Next Earnings

Q2 FY2026 — expected 2026-09-21

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionORGSdiscussed_in_filing Cybersecurity
topic_mentionORGSdiscussed_in_filing Trusted Computing
topic_mentionORGSdiscussed_in_filing Blockchain & Crypto
topic_mentionORGSdiscussed_in_filing Regulation
topic_mentionORGSdiscussed_in_filing Healthcare & Bio
topic_mentionORGSdiscussed_in_filing Cybersecurity
topic_mentionORGSdiscussed_in_filing Trusted Computing
topic_mentionORGSdiscussed_in_filing Blockchain & Crypto
topic_mentionORGSdiscussed_in_filing Regulation
topic_mentionORGSdiscussed_in_filing Healthcare & Bio
topic_mentionORGSdiscussed_in_filing Cybersecurity
topic_mentionORGSdiscussed_in_filing Trusted Computing
topic_mentionORGSdiscussed_in_filing Blockchain & Crypto
topic_mentionORGSdiscussed_in_filing Regulation
topic_mentionORGSdiscussed_in_filing Healthcare & Bio
topic_mentionORGSdiscussed_in_filing Cybersecurity
topic_mentionORGSdiscussed_in_filing Trusted Computing
topic_mentionORGSdiscussed_in_filing Blockchain & Crypto
topic_mentionORGSdiscussed_in_filing Regulation
topic_mentionORGSdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262024-12-310001493152-26-012845EDGAR94K words
2024-04-152023-12-310001493152-24-014652EDGAR
2023-03-222022-12-310001493152-23-008574EDGAR
2022-03-302021-12-310001493152-22-008157EDGAR
2021-03-092020-12-310001493152-21-005653EDGAR
2020-03-092019-12-310001062993-20-001299EDGAR
2019-02-132018-11-300001062993-19-000780EDGAR
2018-02-282017-12-310001062993-18-001019EDGAR
2017-02-282016-11-300001062993-17-001138EDGAR
2016-02-292015-11-300001062993-16-008107EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2024-11-132024-09-300001493152-24-044972EDGAR33K words
2024-08-082024-06-300001493152-24-030760EDGAR
2024-05-202024-03-310001493152-24-020662EDGAR
2023-11-132023-09-300001493152-23-040518EDGAR
2023-08-102023-06-300001493152-23-027624EDGAR
2023-05-102023-03-310001493152-23-016181EDGAR
2022-11-102022-09-300001493152-22-031425EDGAR
2022-08-152022-06-300001493152-22-022915EDGAR
2022-05-232022-03-310001493152-22-014738EDGAR
2021-11-042021-09-300001493152-21-027208EDGAR
2021-08-052021-06-300001493152-21-018694EDGAR
2021-05-062021-03-310001493152-21-010650EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-130001493152-26-010042EDGAR1K words
2026-01-260001493152-26-003501EDGAR
2025-09-160001493152-25-013758EDGAR
2025-08-250001641172-25-025394EDGAR
2025-08-190001641172-25-024840EDGAR
2025-08-010001641172-25-021909EDGAR
2025-06-060001641172-25-014075EDGAR
2025-04-220001641172-25-005702EDGAR
2025-03-060001493152-25-009380EDGAR
2025-01-280001493152-25-003914EDGAR

278 total filings indexed. 246 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001460602
TickerORGS
Exchange
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 20785aef26da22b6c830b0d3a529791894bb599c9860a65a982a9948e7b293cd
parent: 1e8be223fd23c5b63f6c75811abc2ff179c30bd0adb15a9629dcf6f8d14d0e5e
content hash: 65eef5ea5449ab2d999d49d75eb4d9e39b2f7e53186b45de402a974a9d0254cd
signed: 2026-04-13T04:46:45.237Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf